Biohaven Pharmaceutical

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BHVN and other ETFs, options, and stocks.

About BHVN

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. 

CEO
Vladimir Coric
CEOVladimir Coric
Employees
928
Employees928
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2013
Founded2013
Employees
928
Employees928

BHVN Key Statistics

Market cap
10.84B
Market cap10.84B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.72M
Average volume1.72M
High today
$151.90
High today$151.90
Low today
$151.10
Low today$151.10
Open price
$151.78
Open price$151.78
Volume
1.94M
Volume1.94M
52 Week high
$152.56
52 Week high$152.56
52 Week low
$79.01
52 Week low$79.01

BHVN News

Investor's Business Daily 3d
Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test

Biohaven Pharmaceutical (BHVN) said Thursday its experimental ALS treatment failed in a midstage study, leading BHVN stock to dip slightly. X The company test...

Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test

BHVN Earnings

-$3.82
-$2.55
-$1.27
-$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.